Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by Infinityon Jan 03, 2025 4:56pm
182 Views
Post# 36386801

RE:RE:Interesting

RE:RE:Interesting I would like you understand some basic differences.  CG Oncology was founded in 2010.  I believe as a Delaware corp and held privately.  CG Oncology received Fast Track Designation and BTD at the same time beginning of 2024. CG oncology immediately decide to go Public via a modest IPO of 20 Million shares at USD $19.00  and raised $380 Million.  The IPO was managed by Morgan stanley and Goldman Sachs.  IPO Was fully subscribed and trading today at $30 in just a year.  The price never went below the IPO  at $19.00.  They never knce spoke about PRE BTD
FDA must have seen some merit in CGON.  Yes pretty much the majority of the people on this biard don't even think they are a competition.  We keep issuing PP for pennies and believing we will blast off one day very soon!!
<< Previous
Bullboard Posts
Next >>